about
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort studyPrevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetesAssociation between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysisSpatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survivalOral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES IIIQuantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging.Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopyDiffusion-weighted magnetic resonance imaging for the staging of liver fibrosis.Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.The association of arterial shear and flow-mediated dilation in diabetesHigher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes.A randomized trial of exercise for blood pressure reduction in type 2 diabetes: effect on flow-mediated dilation and circulating biomarkers of endothelial function.Effect of exercise on blood pressure in type 2 diabetes: a randomized controlled trial.Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?Oncologic applications of diffusion-weighted MRI in the body.Prevalence of honorary coauthorship in the American Journal of Roentgenology.Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.Rectal imaging: part 1, High-resolution MRI of carcinoma of the rectum at 3 T.Agreement and reproducibility of apparent diffusion coefficient measurements of dual-b-value and multi-b-value diffusion-weighted magnetic resonance imaging at 1.5 Tesla in phantom and in soft tissues of the abdomen.Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.Association between serum uric acid and nonalcoholic fatty liver disease in the US population.Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
P50
Q24596256-A63DB5AA-C7C4-461F-93EA-DB279DD6B608Q28384968-9C79591D-A850-4A4B-A8BA-28B970368ED6Q30496725-B28CA94D-40C0-4D1C-BE36-6C5F69E55C91Q30589720-C75B6AFF-6FB2-4405-96B3-38D0C4909507Q30592294-749AEE4A-78CE-4122-9F49-2EC3A36F984CQ33851755-AD639842-7A63-453A-8149-5FC753824BDAQ33925521-3C737C2C-035E-418D-9FA7-D34383DE7950Q34223422-69899919-9877-45DF-BC41-7AFD1F8FAF9CQ34987278-868818D2-4731-4CA6-BF1C-B8B86F45966CQ35095985-170D1722-DADF-4D27-A6F8-BC624DD35D5AQ35111929-729F6ACD-9C67-4765-B320-763744604F28Q35234472-E536CACA-2C03-450B-8F07-704C64EA70B6Q35427491-15C36D04-D057-4425-B97F-3EA443F3BD21Q36120653-861809D4-CEC9-42AC-8BC0-6B7C4863EB4AQ36282814-2DF48FEF-3357-4269-A8C8-35B0C2CE8662Q36331462-F54C72F8-A750-4B51-86C3-FD34C32DD675Q37330837-5DF26365-DFBE-41A0-8D7B-E3E4DE5D3AE1Q37978220-5F7BF5B6-75C0-4015-BB1B-FAE950813F83Q38012714-DDD869D2-1A7D-4078-B399-1C4B0D6F3608Q38013021-A871765B-BDF2-4F8E-91E1-B6B9BE647579Q38021755-92DEE8BA-0D2D-4667-9C89-A5547D1B304AQ38074295-34DFD60D-CD64-4985-BED7-E6CAC7196BC9Q38101549-EB0F961D-5408-41D8-848D-4968D08F9A12Q41118604-07047C1E-A12A-406A-B0F2-BA572A59FB58Q53060987-03691C47-969A-428B-9307-C0B838CB1582
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Susanne Bonekamp
@ast
Susanne Bonekamp
@en
Susanne Bonekamp
@es
Susanne Bonekamp
@nl
Susanne Bonekamp
@sl
type
label
Susanne Bonekamp
@ast
Susanne Bonekamp
@en
Susanne Bonekamp
@es
Susanne Bonekamp
@nl
Susanne Bonekamp
@sl
prefLabel
Susanne Bonekamp
@ast
Susanne Bonekamp
@en
Susanne Bonekamp
@es
Susanne Bonekamp
@nl
Susanne Bonekamp
@sl
P106
P1153
23395910400
P21
P31
P496
0000-0001-5847-5656